We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Artivion
AORT
$1.3B
| $947K | ﹤0.01% |
56,904
+15,730
| +38% | +$278K |
|
|
BKI
1952
DELISTED
Black Knight, Inc. Common Stock
BKI
| $946K | ﹤0.01% |
24,703
+1,204
| +5% | +$45.3K |
|
|
CBPX
1953
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $946K | ﹤0.01% |
38,631
+1,772
| +5% | +$42.7K |
|
1954
Univest Financial
UVSP
$1.22B
| $944K | ﹤0.01% |
36,445
+784
| +2% | +$22K |
|
1955
Donnelley Financial Solutions
DFIN
$1.16B
| $941K | ﹤0.01% |
48,796
+12,190
| +33% | +$275K |
|
1956
TFS Financial
TFSL
$5.16B
| $941K | ﹤0.01% |
56,617
+2,932
| +5% | +$51.3K |
|
1957
Kadant
KAI
$3.63B
| $939K | ﹤0.01% |
15,824
+362
| +2% | +$22K |
|
1958
Nordic American Tanker
NAT
$1.38B
| $939K | ﹤0.01% |
115,717
+3,715
| +3% | +$30.7K |
|
|
WLH
1959
DELISTED
WILLIAM LYON HOMES
WLH
| $939K | ﹤0.01% |
45,550
+18,891
| +71% | +$353K |
|
1960
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $937K | ﹤0.01% |
39,628
+2,129
| +6% | +$45.5K |
|
|
WEB
1961
DELISTED
Web.com Group, Inc.
WEB
| $936K | ﹤0.01% |
48,503
+1,452
| +3% | +$28.6K |
|
|
LDR
1962
DELISTED
Landauer Inc
LDR
| $935K | ﹤0.01% |
19,170
+5,174
| +37% | +$262K |
|
1963
Center Bancorp
CNOB
$1.66B
| $934K | ﹤0.01% |
38,501
+2,481
| +7% | +$61.3K |
|
|
XYZ
1964
Block Inc
XYZ
$48.4B
| $934K | ﹤0.01% |
54,062
+3,623
| +7% | +$56.7K |
|
|
CHUY
1965
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $934K | ﹤0.01% |
31,350
+9,250
| +42% | +$271K |
|
1966
Haverty Furniture Companies
HVT
$397M
| $933K | ﹤0.01% |
38,315
+10,239
| +36% | +$235K |
|
1967
CBIZ
CBZ
$2.99B
| $930K | ﹤0.01% |
68,659
+2,362
| +4% | +$31.7K |
|
1968
Tredegar Corp
TG
$265M
| $930K | ﹤0.01% |
53,006
+14,024
| +36% | +$292K |
|
1969
Caesarstone
CSTE
$72.3M
| $929K | ﹤0.01% |
25,639
+830
| +3% | +$26.7K |
|
|
NEWR
1970
DELISTED
New Relic, Inc.
NEWR
| $925K | ﹤0.01% |
24,962
+1,806
| +8% | +$63.3K |
|
|
HEES
1971
DELISTED
H&E Equipment Services
HEES
| $924K | ﹤0.01% |
37,668
-232
| -0.6% | -$5.68K |
|
|
FPO
1972
DELISTED
First Potomac Realty Trust
FPO
| $922K | ﹤0.01% |
89,711
+6,204
| +7% | +$63.8K |
|
1973
Cass Information Systems
CASS
$714M
| $920K | ﹤0.01% |
18,366
+596
| +3% | +$29.8K |
|
1974
Matrix Service
MTRX
$326M
| $920K | ﹤0.01% |
55,758
+14,737
| +36% | +$277K |
|
|
FLXN
1975
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $920K | ﹤0.01% |
34,203
+6,825
| +25% | +$139K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.